Recruitment Messages for Current Smokers Recently Diagnosed With Cancer

Health Behavior Clinical Trial

Official title:

A Multimethod Evaluation of Tobacco Treatment Trial Recruitment Messages for Current Smokers Recently Diagnosed With Cancer: Pilot Factorial Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05471284
• Other study ID #: 2018P002035
• Status: Completed
• Phase: N/A
• Start date: February 11, 2019
• Est. completion date: April 2, 2019

Study information

• Verified date: July 2022
• Source: University of Oklahoma
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The objective of this study was to conduct a pilot factorial randomized trial to identify the message frames that are most effective in promoting participation in a tobacco treatment trial for current smokers recently diagnosed with cancer. To do so, we used a multimethod approach to evaluate 3 different message frames across evaluation, effectiveness, and outcome measures. We combine findings from a message design experiment with textual analytic software to provide a holistic understanding of how message frames may or may not differentially affect tobacco treatment trial participation within the context of a cancer diagnosis.

Description:

Background: A cancer diagnosis can catalyze motivation to quit smoking. Tobacco treatment trials offer cessation resources but have low accrual rates. Digital outreach may improve accrual, but knowledge of how best to recruit smokers with recent diagnoses is limited.

Objective: This study aims to identify the message frames that were most effective in promoting intent to talk to a physician about participating in a tobacco treatment trial for smokers recently diagnosed with cancer.

Methods: From February to April 2019, current smokers diagnosed within the past 24 months were recruited from a national web-based panel for a multimethod pilot randomized trial (N=99). Participants were randomized to a 2×3 plus control factorial design that tested 3 unique message frames: proximal versus distal threats of smoking, costs of continued smoking versus benefits of quitting, and gains of participating versus losses of not participating in a tobacco treatment trial.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 99
• Est. completion date: April 2, 2019
• Est. primary completion date: April 1, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Speak and understand English

• A recent cancer diagnosis (within the past 24 months)

• 18 years or older

• Report any cigarette use within the past 30 days

Exclusion Criteria:

• Do not speak or understand English

• Have not been diagnosed with cancer within the past 24 months

• Below the age of 18

• Does not report any cigarette use within the past 30 days

Related Conditions & MeSH terms

• Health Behavior
• Tobacco Smoking

Intervention

Behavioral:
• Proximal
The first factor tested framing of the near, proximal threat of continued smoking.
• Distal
The first factor tested framing of the long-term, distal threat of continued smoking.
• Cost
Cost framework measures the response efficacy to quitting smoking by displaying costs of continued smoking.
• Benefit
Benefit framework measures the response efficacy to quitting smoking by displaying benefits of quitting.
• Loss
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing loss of not participating in a smoking cessation.
• Gain
The third factor tested framing of the response efficacy of participating in a cessation study by utilizing gain of participating in a smoking cessation.
• Control
Does not include any of the three message factors.

Locations

Country	Name	City	State
United States	Jordan Neil	Oklahoma City	Oklahoma

Sponsors (4)

Lead Sponsor	Collaborator
University of Oklahoma	Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, Tufts University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Difference in intent to talk to a physician about participating in a smoking cessation study between factors.	The main effect within each message factor level was examined using ANOVA and compared with the control condition.	Within 30 minutes
Secondary	Predictors of intent to talk to a physician about participating in a smoking cessation study.	Other message evaluation and effectiveness measures were collected and explored in a multivariable model predicting intent to talk to a physician.	Within 30 minutes